OTHER LONG-TERM LIABILITIES

9 Months Ended

Sep. 30, 2022

OTHER LONG-TERM LIABILITIES

OTHER LONG-TERM LIABILITIES

7.    OTHER LONG-TERM LIABILITIES

Other long-term liabilities consist of the following:

	September 30, 2022		December 31, 2021
Technology Investment Agreement (TIA)	$	75,006,588	$	68,955,664
Stock repurchase		—		1,040,666
Total	$	75,006,588	$	69,996,330

The TIA provides for reimbursement to the Company for the purchase of equipment and supplies related to the expansion of the Company’s domestic production of needles and syringes.  Under the TIA, reimbursable amounts will

be reflected as a liability until the time its deferred income can be systematically amortized over a period matching the useful life of the purchased assets.

At December 31, 2021, the stock repurchase liability of amounts payable by the Company to former preferred shareholders as a result of private stock purchases in 2020 (See Note 12) was classified as a long-term liability.  As of March 31, 2022, the final installment of $1,101,110 due in February 2023 was instead classified as Other accrued liabilities on the Condensed Balance Sheets.